Biological effects of irradiating hepatocellular carcinoma cells by internal exposure with 125I-labeled 5-iodo-2'-deoxyuridine-chitosan drug loading nanoparticles
- PMID: 25379613
- PMCID: PMC4224040
- DOI: 10.1089/cbr.2014.1693
Biological effects of irradiating hepatocellular carcinoma cells by internal exposure with 125I-labeled 5-iodo-2'-deoxyuridine-chitosan drug loading nanoparticles
Abstract
In this study, the authors evaluate the biological effects of irradiation of hepatocellular carcinoma cells by internal exposure with (125)I-labeled 5-iodo-2'-deoxyuridine ((125)I-UdR)-chitosan drug loading nanoparticles ((125)I-UdR-CS-DLN). The authors observed that accumulation of nanoparticles was significantly (p<0.05) higher in hepatocellular carcinoma cells HepG2 than normal liver cells HL-7702 after treated with (125)I-UdR-CS-DLN for 30 minutes. Survival of HepG2 cells was significantly lower at (125)I-UdR-CS-DLN doses higher than 37 kBq/mL (more significant in the G1 phase and G2/M phase) than the HL-7702 cells. In addition, (125)I-UdR-CS-DLN induced a higher level of DNA double-strand breaks than (125)I-UdR, and HepG2 cells exhibited a lower level of DNA repair when compared with HL-7702 cells. In vivo animal experiments, TUNEL staining, after targeted treatment, showed that (125)I-UdR-CS-DLN induced significant cell apoptosis in rabbit hepatocellular tumors in situ than (125)I-UdR infusion at the same dose. In conclusion, hepatocellular carcinoma cells were significantly irradiated with (125)I-UdR-CS-DLN compared with (125)I-UdR, and (125)I-UdR-CS-DLN irradiation enhanced DNA damage, induced liver cancer cell apoptosis, and prevented DNA damage repair. However, evaluating the extent of damage and organ sparing in vivo should also be considered.
Keywords: 125I-UdR-CS-DLN; biological effects; liver cancer; nanoparticles; passive targeting.
Figures





References
-
- Ma XD, Larry ED, Jerry RW. Local delivery of polymeric 125I-IUdR to experimental human malignant gliomas. Chin J Neurosurg Dis Res 2004;4:293
-
- Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol Oncol 2008;26:57. - PubMed
-
- Yang C, Liu F, Song M, et al. . Preparation and in vitro evaluation of chitosan nanoparticles containing 5-[125I] Iodo-2′-deoxyuridine. Clin J Radiol Med Prot 2010;30:650
-
- Tanima B, Susmita M, Ajay KS, et al. . Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm 2002;243:93. - PubMed
-
- Wang K, Yin R, Tong Z, et al. . Synthesis and characterization of water-soluble glucosyloxyethyl acrylate modified chitosan. Int J Biol Macromol 2011;48:753. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical